Ardelyx Inc (ARDX)
5.80
-0.09
(-1.53%)
USD |
NASDAQ |
Nov 05, 11:28
Ardelyx Debt to Equity Ratio: 0.6362 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.6362 |
| June 30, 2024 | 0.682 |
| March 31, 2024 | 0.6616 |
| December 31, 2023 | 0.2987 |
| September 30, 2023 | 0.1424 |
| June 30, 2023 | 0.2196 |
| March 31, 2023 | 0.2143 |
| December 31, 2022 | 0.2716 |
| September 30, 2022 | 0.397 |
| June 30, 2022 | 0.4972 |
| March 31, 2022 | 0.4072 |
| December 31, 2021 | 0.3905 |
| September 30, 2021 | 0.6321 |
| June 30, 2021 | 0.4359 |
| March 31, 2021 | 0.39 |
| December 31, 2020 | 0.4027 |
| September 30, 2020 | 0.3859 |
| June 30, 2020 | 0.3447 |
| March 31, 2020 | 0.2994 |
| December 31, 2019 | 0.2679 |
| September 30, 2019 | 1.013 |
| June 30, 2019 | 0.7228 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.5379 |
| December 31, 2018 | 0.4249 |
| September 30, 2018 | 0.3466 |
| June 30, 2018 | 0.2988 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1424
Minimum
Sep 2023
0.682
Maximum
Jun 2024
0.3988
Average
0.3902
Median
Debt to Equity Ratio Benchmarks
| Verve Therapeutics Inc | 0.00 |
| United Therapeutics Corp | 0.0656 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 367.86M |
| Total Liabilities (Quarterly) | 209.57M |
| Shareholders Equity (Quarterly) | 158.30M |
| Current Ratio | 4.030 |
| Net Debt Paydown Yield | -0.90% |